Paul J. Fanning
Personalreferent bei ATEA PHARMACEUTICALS, INC.
Aktive Positionen von Paul J. Fanning
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ATEA PHARMACEUTICALS, INC. | Personalreferent | - | - |
Karriereverlauf von Paul J. Fanning
Ehemalige bekannte Positionen von Paul J. Fanning
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
RADIUS HEALTH, INC. | Personalreferent | 01.12.2019 | 01.08.2020 |
IDENIX PHARMACEUTICALS INC | Personalreferent | 01.03.2004 | 01.01.2014 |
Invensys Process Systems, Inc.
Invensys Process Systems, Inc. Packaged SoftwareTechnology Services Invensys Process Systems, Inc. develops software applications and provides consulting services. It also offers process automation and safety systems, manufacturing operations and optimization software, and plant-to-business intelligence solutions. The company is headquartered in Foxboro, MA. | Personalreferent | 01.01.2000 | 01.01.2004 |
TETRAPHASE PHARMACEUTICALS, INC. | Personalreferent | 01.01.2015 | - |
Ausbildung von Paul J. Fanning
Babson College | Masters Business Admin |
University of Massachusetts | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 8 |
Operativ
Human Resources Officer | 5 |
Masters Business Admin | 1 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 5 |
Consumer Services | 3 |
Technology Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ATEA PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
Idenix Pharmaceuticals LLC
Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Idenix Pharmaceuticals LLC is a biopharmaceutical company, which is engaged in the discovery and development of drugs for the treatment of human viral diseases with operations in the United States and France. Currently, its primary research and development focus is on the treatment of patients with hepatitis C virus, or HCV, using nucleotide polymerase inhibitors and NS5A inhibitors. Idenix Pharmaceuticals was founded by Jean-Pierre Sommadossi and Raymond F. Schinazi in May 1998 and is headquartered in Cambridge, MA. | Health Technology |
Invensys Process Systems, Inc.
Invensys Process Systems, Inc. Packaged SoftwareTechnology Services Invensys Process Systems, Inc. develops software applications and provides consulting services. It also offers process automation and safety systems, manufacturing operations and optimization software, and plant-to-business intelligence solutions. The company is headquartered in Foxboro, MA. | Technology Services |
Radius Health, Inc.
Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
Tetraphase Pharmaceuticals, Inc.
Tetraphase Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetraphase Pharmaceuticals, Inc. is engaged in the development and production of novel tetracyclines for serious and life-threatening bacterial infections. It also develops eravacycline, a synthetic fluorocycline, as an intravenous and oral antibiotic for use as a first-line empiric monotherapy for the treatment of resistant and multi-drug-resistant infections. The company was founded on July 7, 2006 and is headquartered in Waltham, MA. | Health Technology |
- Börse
- Insiders
- Paul J. Fanning
- Erfahrung